News

SAN DIEGO, March 15, 2022 /PRNewswire/ -- Molecular Assemblies, Inc., today announced that it has raised a $25.8 million Series B financing with participation from new investor, Casdin Capital ...
--Codexis, Inc., a leading enzyme engineering company enabling the promise of synthetic biology, and Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, today announced ...
Molecular Assemblies, Inc., ("MAI" or the "Company") a pioneer and leader in the field of enzymatic DNA synthesis, today announced the achievement of key milestones for therapeutic DNA target ...
Cornell researchers have found a new and potentially more accurate way to see what proteins are doing inside living ...
Molecular Assemblies’ Key Customer Programme provides select researchers priority access to long, custom oligonucleotides synthesized with the company’s FES technology. This program is expected to ...
Marvai LifeSciences has acquired assets and intellectual property from Molecular Assemblies at undisclosed terms. Marvai, a San Diego company, said Tuesday that the acquisition would expand the ...
Molecular Assemblies, pioneer of its Fully Enzymatic SynthesisTM (FESTM) technology to provide researchers long, pure, and accurate DNA oligonucleotides is focused on removing today's limitations ...
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today its acquisition of intellectual property ...
Molecular assembly is a fundamental concept in nanotechnology that involves the controlled arrangement of molecules or molecular components into ordered structures with desired properties and ...